Chuck Royce's TMDX Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 244,382 shares of TransMedics Group, Inc. (TMDX) worth $24.29 M, representing 0.24% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in TMDX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 210,000 shares. Largest reduction occurred in Q2 2025, reducing 49,799 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's TransMedics Group (TMDX) Holding Value Over Time
Track share changes against reported price movement
Quarterly TransMedics Group (TMDX) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1,233 | Add 0.51% | 244,382 | $99.41 |
| Q3 2025 | -4,252 | Reduce 1.72% | 243,149 | $112.20 |
| Q2 2025 | -49,799 | Reduce 16.76% | 247,401 | $134.01 |
| Q1 2025 | +2 | Add 0.00% | 297,200 | $67.28 |
| Q3 2024 | -4,000 | Reduce 1.33% | 297,198 | $157.00 |
| Q2 2024 | -14,000 | Reduce 4.44% | 301,198 | $150.62 |
| Q1 2024 | -36,500 | Reduce 10.38% | 315,198 | $73.94 |
| Q4 2023 | +210,000 | Add 148.20% | 351,698 | $78.93 |
| Q3 2023 | +4,198 | Add 3.05% | 141,698 | $54.75 |
| Q2 2023 | -22,000 | Reduce 13.79% | 137,500 | $83.98 |
| Q1 2023 | -32,500 | Reduce 16.93% | 159,500 | $75.73 |
| Q4 2022 | +40,000 | Add 26.32% | 192,000 | $61.72 |
| Q3 2022 | +10,000 | Add 7.04% | 152,000 | $41.74 |
| Q2 2022 | +55,000 | Add 63.22% | 142,000 | $31.45 |
| Q1 2022 | +26,000 | Add 42.62% | 87,000 | $26.94 |
| Q4 2021 | +61,000 | New Buy | 61,000 | $19.16 |
| Q4 2020 | -41,000 | Sold Out | 0 | $0.00 |
| Q3 2020 | +41,000 | New Buy | 41,000 | $13.78 |
Chuck Royce's TransMedics Group Investment FAQs
Chuck Royce first purchased TransMedics Group, Inc. (TMDX) in Q3 2020, acquiring 41,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held TransMedics Group, Inc. (TMDX) for 20 quarters since Q3 2020.
Chuck Royce's largest addition to TransMedics Group, Inc. (TMDX) was in Q4 2023, adding 351,698 shares worth $27.76 M.
According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 244,382 shares of TransMedics Group, Inc. (TMDX), valued at approximately $24.29 M.
As of the Q1 2026 filing, TransMedics Group, Inc. (TMDX) represents approximately 0.24% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in TransMedics Group, Inc. (TMDX) was 351,698 shares, as reported at the end of Q4 2023.